These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35484309)

  • 1. A randomised study to assess the nicotine pharmacokinetics of an oral nicotine pouch and two nicotine replacement therapy products.
    Azzopardi D; Ebajemito J; McEwan M; Camacho OM; Thissen J; Hardie G; Voisine R; Mullard G; Cohen Z; Murphy J
    Sci Rep; 2022 Apr; 12(1):6949. PubMed ID: 35484309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomised Study to Investigate the Nicotine Pharmacokinetics of Oral Nicotine Pouches and a Combustible Cigarette.
    McEwan M; Azzopardi D; Gale N; Camacho OM; Hardie G; Fearon IM; Murphy J
    Eur J Drug Metab Pharmacokinet; 2022 Mar; 47(2):211-221. PubMed ID: 34923602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell).
    Dautzenberg B; Nides M; Kienzler JL; Callens A
    BMC Clin Pharmacol; 2007 Oct; 7():11. PubMed ID: 17922899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised, crossover, clinical study to assess nicotine pharmacokinetics and subjective effects of the BIDI
    Fearon IM; Gilligan K; Seltzer RGN; McKinney W
    Harm Reduct J; 2022 Jun; 19(1):57. PubMed ID: 35655314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic Characterization of a Prototype Mini Nicotine Lozenge.
    Lai PM; Araga M; Hamilton A; Armogida M
    Adv Ther; 2021 Jul; 38(7):3997-4012. PubMed ID: 34105089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the Abuse Potential in Adult Smokers of a Novel Oral Tobacco Product Relative to Combustible Cigarettes and Nicotine Polacrilex Gum.
    Liu J; Wang J; Vansickel A; Edmiston J; Graff D; Sarkar M
    Clin Pharmacol Drug Dev; 2021 Mar; 10(3):241-250. PubMed ID: 33502815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety profile of a nicotine lozenge compared with that of nicotine gum in adult smokers with underlying medical conditions: a 12-week, randomized, open-label study.
    Marsh HS; Dresler CM; Choi JH; Targett DA; Gamble ML; Strahs KR
    Clin Ther; 2005 Oct; 27(10):1571-87. PubMed ID: 16330293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical characterization of tobacco-free "modern" oral nicotine pouches and their position on the toxicant and risk continuums.
    Azzopardi D; Liu C; Murphy J
    Drug Chem Toxicol; 2022 Sep; 45(5):2246-2254. PubMed ID: 34034614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An abuse liability assessment of the glo tobacco heating product in comparison to combustible cigarettes and nicotine replacement therapy.
    Hardie G; Gale N; McEwan M; Oscar SM; Ziviani L; Proctor CJ; Murphy J
    Sci Rep; 2022 Aug; 12(1):14701. PubMed ID: 36038580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine replacement therapy for smoking cessation.
    Stead LF; Perera R; Bullen C; Mant D; Hartmann-Boyce J; Cahill K; Lancaster T
    Cochrane Database Syst Rev; 2012 Nov; 11():CD000146. PubMed ID: 23152200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a nicotine lozenge for smoking cessation.
    Shiffman S; Dresler CM; Hajek P; Gilburt SJ; Targett DA; Strahs KR
    Arch Intern Med; 2002 Jun; 162(11):1267-76. PubMed ID: 12038945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized Trial to Compare Smoking Cessation Rates of Snus, With and Without Smokeless Tobacco Health-Related Information, and a Nicotine Lozenge.
    Nelson PR; Chen P; Battista DR; Pillitteri JL; Shiffman S
    Nicotine Tob Res; 2019 Jan; 21(1):88-94. PubMed ID: 29373698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised, open-label, cross-over clinical study to evaluate the pharmacokinetic, pharmacodynamic and safety and tolerability profiles of tobacco-free oral nicotine pouches relative to cigarettes.
    Chapman F; McDermott S; Rudd K; Taverner V; Stevenson M; Chaudhary N; Reichmann K; Thompson J; Nahde T; O'Connell G
    Psychopharmacology (Berl); 2022 Sep; 239(9):2931-2943. PubMed ID: 35732751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose pharmacokinetics of nicotine when given with a novel mouth spray for nicotine replacement therapy.
    Kraiczi H; Hansson A; Perfekt R
    Nicotine Tob Res; 2011 Dec; 13(12):1176-82. PubMed ID: 21849415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of acute exercise on cigarette cravings while using a nicotine lozenge.
    Tritter A; Fitzgeorge L; Prapavessis H
    Psychopharmacology (Berl); 2015 Jul; 232(14):2531-9. PubMed ID: 25701265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abuse liability assessment of the JUUL system in four flavors relative to combustible cigarette, nicotine gum and a comparator electronic nicotine delivery system among adult smokers.
    Goldenson NI; Buchhalter AR; Augustson EM; Rubinstein ML; Henningfield JE
    Drug Alcohol Depend; 2020 Dec; 217():108395. PubMed ID: 33176942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Single-Dose, Crossover-Design Bioequivalence Study Comparing Two Nicotine Gum Formulations in Healthy Subjects.
    Du D
    Adv Ther; 2018 Aug; 35(8):1169-1180. PubMed ID: 30027479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine replacement treatment, e-cigarettes and an online behavioural intervention to reduce relapse in recent ex-smokers: a multinational four-arm RCT.
    McRobbie HJ; Phillips-Waller A; El Zerbi C; McNeill A; Hajek P; Pesola F; Balmford J; Ferguson SG; Li L; Lewis S; Courtney RJ; Gartner C; Bauld L; Borland R
    Health Technol Assess; 2020 Dec; 24(68):1-82. PubMed ID: 33270009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking cessation among US adults: use of e-cigarettes, including JUUL, and NRT use.
    Patel M; Cuccia AF; Zhou Y; Kierstead EC; Briggs J; Schillo BA
    Tob Control; 2021 Nov; 30(6):693-695. PubMed ID: 32958602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions to reduce harm from continued tobacco use.
    Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.